z-logo
open-access-imgOpen Access
Safety of Thrombolysis in Patients With Acute Ischemic Stroke and Cerebral Cavernous Malformations
Author(s) -
Hebun Erdur,
Jan F. Scheitz,
Serdar Tütüncü,
Jochen B. Fiebach,
Matthias Endres,
David J. Werring,
Christian H. Nolte
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.004559
Subject(s) - medicine , interquartile range , thrombolysis , intracerebral hemorrhage , stroke (engine) , intraparenchymal hemorrhage , surgery , subarachnoid hemorrhage , mechanical engineering , myocardial infarction , engineering
Data on safety of intravenous thrombolysis with recombinant tissue-type plasminogen activator for acute ischemic stroke in patients with coexisting cerebral cavernous malformations (CCMs) are scarce. We assessed the risk of thrombolysis-associated hemorrhage in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom